SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as discussions revolve around a potential short squeeze, fueled by high short interest and anticipation of upcoming news or contract announcements. The community is weighing in on share authorization and comparing BBAI to other AI and defense sector plays like Palantir, while also noting executive leadership's background in government. Technical analysis and mentions of potential catalysts are adding to the speculative buzz.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a significant surge, leading to community discussions around potential short squeezes and high volatility. Traders are actively debating entry and exit strategies, with some pointing to the stock's low float as a catalyst for dramatic price movements. The stock's performance is also drawing comparisons to similar situations and prompting speculation about related sectors.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as community members discuss recent price movement and potential catalysts. Bullish sentiment appears tied to speculation around new contracts and the company's long-term prospects, while some bears believe the stock is overbought. The conversation also mentions potential competition and market manipulation.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as community members discuss positive biomarker data and speculate about FDA feedback, expected by year-end, potentially leading to accelerated approval. Chatter revolves around a possible buyout or partnership, with some investors focused on potential short squeezes and related trading activity. The community is closely monitoring developments and expressing excitement about the company's prospects.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending due to strong consolidation and a potential breakout, with community members pointing to significant call buying activity and discussing the possibility of a gamma squeeze. The stock's agentic AI ambitions and partnerships with major tech players like NVIDIA and Google are also fueling bullish sentiment. Some traders are taking profits, while others remain long, anticipating further upside and comparing PATH to other high-growth AI stocks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amidst discussions about a potential short squeeze and speculation around upcoming catalysts, including the BFS report. Community members are debating the impact of recent developments, such as the copper powder stockpile acquisition, with some expressing concerns about dilution and transparency, while others highlight the strategic importance of securing non-Chinese supply chains. Overall, the stock's movement is tied to sentiment around rare earth miners and anticipation for key company updates.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as community members discuss the potential for a short squeeze and the upcoming satellite launch, with some speculating about government contracts and partnerships. Bullish sentiment is fueled by the potential for advances in space-based cellular broadband and speculation about the company's long-term prospects in the growing space economy. Some traders are pointing to technical indicators suggesting a potential breakout, while others caution about chasing momentum.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies ($QCLS) is trending as traders discuss a potential short squeeze and the influence of investor Martin Shkreli, who has announced a position in the company. Community members are actively debating price targets and the stock's potential within the photonics sector, comparing it to other recent runners like $SMX. Bullish sentiment seems to be building, with many anticipating a continued upward trend.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as discussions focus on a recent surge, with some attributing it to a broader market rally and potential short squeeze while others remain skeptical of the company's fundamentals and question its long-term viability in the quantum computing sector; community members are debating whether the stock's upward movement is sustainable or a temporary pump before a potential correction.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai ($AI) is trending amid mixed sentiment following its latest earnings report and wider Q3 updates, with community members debating whether the market has overreacted to cautious guidance despite the company beating estimates. A new Health and Human Services contract is also fueling bullish speculation of a short squeeze given the stock's high short interest and top leadership being former military staff with government connections. However, concerns remain around revenue decline, margin pressure, and increased losses, with some speculating a potential sale of the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carlson Capital L.P. Makes New Investment in CureVac N.V. $CVAC

Carlson Capital L.P. bought a new position in CureVac N.V. (NASDAQ:CVAC - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange...

CureVac (NASDAQ:CVAC) Sees Large Volume Increase - Here's What Happened

CureVac (NASDAQ:CVAC) Sees Large Volume Increase - Still a Buy...

Company News for Nov 25, 2025

Companies In The News Are: CVAC, CAAP, NVO, BABA.

CureVac N.V. (NASDAQ:CVAC) Given Consensus Rating of "Hold" by Brokerages

Shares of CureVac N.V. (NASDAQ:CVAC - Get Free Report) have been given an average rating of "Hold" by the six analysts that are presently covering the stock, MarketBeat.com reports. Five research...

Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates

Immatics (IMTX) delivered earnings and revenue surprises of +2.00% and -50.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of -12.50% and +1.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Quinn Opportunity Partners LLC Acquires 204,073 Shares of CureVac N.V. $CVAC

Quinn Opportunity Partners LLC grew its stake in CureVac N.V. (NASDAQ:CVAC - Free Report) by 305.3% during the second quarter, according to the company in its most recent filing with the Securities...

Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of +20.78% and +3.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Beats Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +19.35% and +1.12%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Oncobiologics (OTLK) delivered earnings and revenue surprises of -4.76% and -40.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Current Price	$5.14
Prev Close	$5.16
Open	$5.21
Dividend Yield	0.00%
50-Day Moving Average	$5.32
Beta	1.02
Avg. Volume	1.36M
PE Ratio	7.18

52-Week High	$5.72
52-Week Low	$2.48
Market Capitalization	$1.16B
EPS (Annual)	$0.7819
Price to Book	1.14
Revenue Per Employee	$588,910.74
Enterprise Value/EBITDA	N/A

CVAC
CureVac N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CVAC News

CVACCureVac N.V.